Quantitative analysis of motor unit action potentials in the subclavian muscle of healthy horses.

This study examines the use of motor unit action potentials (MUAP) for the analysis of the subclavian muscle in healthy horses, aiming to demonstrate the utility and clinical relevance of this method in identifying potential muscle and nerve problems in horses.

Objective of the Study

• The study aims to assess the usability of motor unit action potentials (MUAP) in the study of horse musculature, specifically focusing on the subclavian muscle. By analyzing these bioelectric signals from nerves stimulating the muscles, researchers aim to establish base values for healthy horses, providing a metric for comparison in diagnosing neuromuscular diseases.

Methodology

• Multiple parameters including insertional activity, spontaneous activity, recruitment patterns, and temperate were measured in the electromyographic examination of the subclavian muscle in 10 healthy Dutch Warmblood horses.
• The key data recorded from the MUAP was the amplitude, duration, number of phases, and number of direction changes (“turns”).
• These measurements were carefully analyzed to establish baseline values for the subclavian muscle in the sample group of horses.

Findings

• The average duration of insertional activity was found to be 471.7 milliseconds.
• The mean MUAP amplitude was recorded as 379 RV.
• The average MUAP duration of the subclavian muscle in the subject horses was 727 milliseconds.
• The mean number of phases and turns was recorded as 2.9 and 3.0 respectively.
• The prevalence of polyphasic MUAP (motor unit action potentials with more than four phases) was 77%, and the occurrence of those with more than 5 turns was 2.4%.
• Satellite potentials were detected in 1.0% of the MUAP.

Conclusions and Clinical Relevance

• The results showed that electromyographic analysis, including MUAP analysis, can be conducted effectively in horses.
• The values obtained for the subclavian muscle in healthy adult horses could facilitate future benchmarking and comparative diagnosis of neuromuscular diseases.